| | | |   | | | | By Matthew Herper Ruby Wallau for STAT Medicare’s proposal applies to a particular class of Alzheimer’s drugs, which could also include new entrants over the next few years. Read More | | By Katie Palmer Justin Sullivan/Getty Image CVS Health, Abbott, and other companies that have poured money into developing and distributing Covid-19 tests see an on-ramp to new markets. Read More | | By H. Gilbert Welch and Barnett Kramer Jacqueline Larma/AP A bill in Congress would require Medicare to cover annual liquid biopsies for the early detection of cancer. That's a bad idea. Read More | | Sponsor content by Amgen How does a molecule go from discovery to development? Getting a medicine from the lab into the hands of patients doesn't come easily, as David Reese, Executive Vice President, Research and Development at Amgen, will tell you. "It takes more than a village — it takes an army that has worked for many years. That's why we're here, it's why I come to work every day." Hear from David, scientists, and researchers about what it takes to bring a molecule from discovery to development. | | By Jeff Goldsmith Adobe Health enterprises can be thought of as interlocking circles of trust. For digital health to succeed, it must foster that kind of trust. Read More | |
No comments